22nd Century Group (Nasdaq: XXII) Issues Annual Letter to Shareholders
April 28, 2022 09:30 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., April 28, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
22nd Century Group (Nasdaq: XXII) to Participate in A.G.P./Alliance Global Partner’s Virtual Spring Consumer Cannabis Conference
April 27, 2022 09:25 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., April 27, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2022 Results on May 5, 2022
April 14, 2022 08:00 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., April 14, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
First Cigarette That "Helps You Smoke Less" Launches National Pilot in Chicagoland
April 13, 2022 08:00 ET
|
22nd Century Group, Inc
VLN® cigarettes from 22nd Century Group (Nasdaq: XXII) contain 95% less nicotine than conventional cigarettes; now available in select Circle K convenience stores CHICAGO, April 13, 2022 (GLOBE...
22nd Century (Nasdaq: XXII) Appoints Dr. Calvin Treat as Chief Scientific Officer
April 11, 2022 09:25 ET
|
22nd Century Group, Inc
Further Enhances 22nd Century Group’s Deep Expertise in Plant-Based Biotechnology BUFFALO, N.Y., April 11, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural...
FDA Authorized Reduced-Nicotine Cigarette from 22nd Century Group (Nasdaq: XXII) That ‘Helps You Smoke Less’ Obtains Illinois Tobacco Product Listing
March 28, 2022 09:28 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., March 28, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), today announced that it has received notification from the Office of the Illinois Attorney General’s...
22nd Century Group (Nasdaq: XXII) to Host Investor Meetings at Roth Capital Conference March 14-15
March 09, 2022 09:30 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., March 09, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
22nd Century Group, VLN®의 첫 해외 시장 출시국으로 한국 선정
March 01, 2022 20:05 ET
|
22nd Century Group, Inc
미국 뉴욕주 버팔로, March 02, 2022 (GLOBE NEWSWIRE) -- 농업 바이오테크 기업으로 담배위해감소, 니코틴 저감 담배, 첨단 식물과학을 통한 보건 및 건강 증진 분야에 주력하는 22nd Century Group, Inc. (Nasdaq: XXII)은 자사의 니코틴 저감 담배 VLN®에 대한 첫 해외 판매 시장으로 16억 달러...
22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2021
March 01, 2022 06:00 ET
|
22nd Century Group, Inc
Secured FDA MRTP Authorization for VLN® King and VLN® Menthol King Reduced Nicotine Content CigarettesAdvancing to U.S. Pilot Market Launch in ChicagoAnnounced Circle K as First VLN® Retail Trade...
22nd Century Group Announces South Korea as First VLN® International Market
February 28, 2022 10:05 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Feb. 28, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...